Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2021 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Results by year

Filters applied: . Clear all
Page 1
Autoimmune encephalitis during pregnancy: A diagnostic and therapeutic challenge-A systematic review with individual patients' analysis and clinical recommendations.
Dono F, Consoli S, Tappatà M, Evangelista G, Russo M, Lanzone J, Pozzilli V, Nucera B, Rinaldi F, Di Pietro M, Tinti L, Troisi S, Calisi D, D'Apolito M, Narducci F, Assenza G, Anzellotti F, Brigo F, Vollono C, Onofrj M, Sensi SL, Michelucci R. Dono F, et al. Among authors: rinaldi f. Epilepsia Open. 2023 Dec;8(4):1221-1240. doi: 10.1002/epi4.12806. Epub 2023 Sep 15. Epilepsia Open. 2023. PMID: 37562964 Free PMC article. Review.
Alemtuzumab-induced autoimmune thyroid events in patients with relapsing-remitting multiple sclerosis: A real-life and monocentric experience at a tertiary-level centre.
Manso J, Zhu YH, Margoni M, Rinaldi F, Censi S, Carducci S, Cosma C, Plebani M, Gallo P, Mian C. Manso J, et al. Among authors: rinaldi f. Clin Endocrinol (Oxf). 2022 Sep;97(3):331-338. doi: 10.1111/cen.14616. Epub 2021 Nov 1. Clin Endocrinol (Oxf). 2022. PMID: 34724236
RESULTS: AIATEs developed in 39% of patients a mean 17 months 11 after the first cycle of alemtuzumab. The most common AIATEs were GD (64%), followed by Hashimoto's thyroiditis with hypothyroidism (23%), TSH-receptor-antibody (TRAb)-positive hypothyroidism (9%), and …
RESULTS: AIATEs developed in 39% of patients a mean 17 months 11 after the first cycle of alemtuzumab. The most common AIATEs were GD (64%), …
A follow-up 18F-FDG brain PET study in a case of Hashimoto's encephalopathy causing drug-resistant status epilepticus treated with plasmapheresis.
Pari E, Rinaldi F, Premi E, Codella M, Rao R, Paghera B, Panarotto MB, De Maria G, Padovani A. Pari E, et al. Among authors: rinaldi f. J Neurol. 2014 Apr;261(4):663-7. doi: 10.1007/s00415-013-7228-0. Epub 2014 Jan 5. J Neurol. 2014. PMID: 24390201
Hashimoto's encephalopathy (HE) is a rare neuropsychiatric syndrome associated with antithyroid antibodies. ...We here describe a case of encephalopathy presenting as non-convulsive status epilepticus associated with Hashimoto's thyroiditis (HT), unres …
Hashimoto's encephalopathy (HE) is a rare neuropsychiatric syndrome associated with antithyroid antibodies. ...We here describ …